BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34792022)

  • 1. Are the washout values currently accepted for lesion characterization in dedicated adrenal CT adequate for diagnosis?
    Gündoğdu E; Oğuzman M; Emekli E; Kebapçı M
    Diagn Interv Radiol; 2021 Nov; 27(6):694-702. PubMed ID: 34792022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation.
    Park SH; Kim MJ; Kim JH; Lim JS; Kim KW
    Korean J Radiol; 2007; 8(4):328-35. PubMed ID: 17673844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Energy-Derived Metrics for Differentiating Adrenal Adenomas From Nonadenomas on Single-Phase Contrast-Enhanced CT.
    Loonis AT; Yu H; Glazer DI; Bay CP; Sodickson AD
    AJR Am J Roentgenol; 2023 May; 220(5):693-704. PubMed ID: 36416399
    [No Abstract]   [Full Text] [Related]  

  • 4. Adrenal Adenomas versus Metastases: Diagnostic Performance of Dual-Energy Spectral CT Virtual Noncontrast Imaging and Iodine Maps.
    Nagayama Y; Inoue T; Oda S; Tanoue S; Nakaura T; Ikeda O; Yamashita Y
    Radiology; 2020 Aug; 296(2):324-332. PubMed ID: 32452733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoma characterization: adrenal protocol with dual-energy CT.
    Kim YK; Park BK; Kim CK; Park SY
    Radiology; 2013 Apr; 267(1):155-63. PubMed ID: 23329655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Quantitative MRI and CT Washout Analysis for Differentiation of Adrenal Pheochromocytoma From Adrenal Adenoma.
    Schieda N; Alrashed A; Flood TA; Samji K; Shabana W; McInnes MD
    AJR Am J Roentgenol; 2016 Jun; 206(6):1141-8. PubMed ID: 27011100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of adrenal lesions using MDCT wash-out parameters: diagnostic accuracy of several combinations of intermediate and delayed phases.
    Foti G; Malleo G; Faccioli N; Guerriero A; Furlani L; Carbognin G
    Radiol Med; 2018 Nov; 123(11):833-840. PubMed ID: 29923085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT time-attenuation washout curves of adrenal adenomas and nonadenomas.
    Korobkin M; Brodeur FJ; Francis IR; Quint LE; Dunnick NR; Londy F
    AJR Am J Roentgenol; 1998 Mar; 170(3):747-52. PubMed ID: 9490968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT sensitivity for adrenal adenoma according to lesion size.
    Park SY; Park BK; Park JJ; Kim CK
    Abdom Imaging; 2015 Oct; 40(8):3152-60. PubMed ID: 26254908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience.
    Hamrahian AH; Ioachimescu AG; Remer EM; Motta-Ramirez G; Bogabathina H; Levin HS; Reddy S; Gill IS; Siperstein A; Bravo EL
    J Clin Endocrinol Metab; 2005 Feb; 90(2):871-7. PubMed ID: 15572420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative Enhancement Ratio of Portal Venous Phase to Unenhanced CT in the Diagnosis of Lipid-poor Adrenal Adenomas.
    Nagayama Y; Inoue T; Kato Y; Tanoue S; Kidoh M; Oda S; Nakaura T; Hirai T
    Radiology; 2021 Nov; 301(2):360-368. PubMed ID: 34463552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing adrenal adenomas from nonadenomas: combined use of diagnostic parameters of unenhanced and short 5-minute dynamic enhanced CT protocol.
    Kamiyama T; Fukukura Y; Yoneyama T; Takumi K; Nakajo M
    Radiology; 2009 Feb; 250(2):474-81. PubMed ID: 19037020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values.
    Korobkin M; Brodeur FJ; Yutzy GG; Francis IR; Quint LE; Dunnick NR; Kazerooni EA
    AJR Am J Roentgenol; 1996 Mar; 166(3):531-6. PubMed ID: 8623622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenal nonhyperfunctioning adenoma and nonadenoma: CT attenuation value as discriminative index.
    Miyake H; Takaki H; Matsumoto S; Yoshida S; Maeda T; Mori H
    Abdom Imaging; 1995; 20(6):559-62. PubMed ID: 8580753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
    Szolar DH; Korobkin M; Reittner P; Berghold A; Bauernhofer T; Trummer H; Schoellnast H; Preidler KW; Samonigg H
    Radiology; 2005 Feb; 234(2):479-85. PubMed ID: 15671003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal Adenoma and Pheochromocytoma: Comparison of Multidetector CT Venous Enhancement Levels and Washout Characteristics.
    Northcutt BG; Trakhtenbroit MA; Gomez EN; Fishman EK; Johnson PT
    J Comput Assist Tomogr; 2016; 40(2):194-200. PubMed ID: 26978001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed enhanced CT of lipid-poor adrenal adenomas.
    Caoili EM; Korobkin M; Francis IR; Cohan RH; Dunnick NR
    AJR Am J Roentgenol; 2000 Nov; 175(5):1411-5. PubMed ID: 11044054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pheochromocytomas Versus Adenoma: Role of Venous Phase CT Enhancement.
    Mohammed MF; ElBanna KY; Ferguson D; Harris A; Khosa F
    AJR Am J Roentgenol; 2018 May; 210(5):1073-1078. PubMed ID: 29570377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT.
    Szolar DH; Kammerhuber FH
    Radiology; 1998 May; 207(2):369-75. PubMed ID: 9577483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of Adrenal Hyperplasia From Adenoma by Use of CT Densitometry and Percentage Washout.
    Park SY; Park BK; Park JJ; Kim CK
    AJR Am J Roentgenol; 2016 Jan; 206(1):106-12. PubMed ID: 26700341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.